Sectoral Asset Management Inc Uni Qure N.V. Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $1.65 Million - $2.42 Million	292,592 New	292,592 $1.98 Million
Q3 2020 Nov 13, 2020	SELL	$35.98 - $47.66 $9.04 Million - $12 Million	-251,158 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $3.95 Million - $5.94 Million	87,758 Added 53.71%	251,158 $11.3 Million
Q1 2020 May 13, 2020	BUY	$40.01 - $73.97 $3.04 Million - $5.61 Million	75,900 Added 86.74%	163,400 $7.75 Million
Q4 2019 Feb 12, 2020	BUY	$37.13 - $74.62 $2.15 Million - $4.33 Million	58,000 Added 196.61%	87,500 $6.27 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $590,400 - $1.15 Million	15,000 Added 103.45%	29,500 $1.16 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $765,020 - $1.19 Million	14,500 New	14,500 $1.13 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.